Literature DB >> 6988023

[Therapeutic use of immunoglobulins in children (author's transl)].

W H Hitzig.   

Abstract

The indications for immunoglobulin therapy in childhood have been well established for many years: prophylaxis is effective with single small doses, a full substitution needs multiple large applications. All other recommendations are ill-defined and result from wishful thinking rather than from solid clinical data. New is the possibility of safe i. v. Ig-application which could be realized through appropriate modification of gammaglobulin preparations. Some properties of the commercially available products are summarized. Our own experience with one of them is encouraging: as a matter of fact, fully effective gammaglobulin substitution is now possible in patients with antibody deficiency syndrome.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6988023     DOI: 10.1007/BF01008579

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  26 in total

Review 1.  [GAMMA GLOBULIN THERAPY. CHEMICAL, IMMUNOLOGICAL AND CLINICAL PRINCIPLES].

Authors:  S BARANDUN
Journal:  Bibl Haematol       Date:  1964

2.  [THERAPY OF TETANUS WITH THE USE OF HUMAN TETANUS ANTITOXIN IN THE FORM OF GAMMA GLOBULIN (TETANUS HYPERIMMUNE GLOBULIN)].

Authors:  R VOSS; H R SCHOEN; L KOERNER; H LALLEMAND; L GRABOW
Journal:  Munch Med Wochenschr       Date:  1965-04-23

3.  Intravenous use of plasmin treated immunoglobulin G. I. Preliminary report on tolerance by immunologically deficient patients.

Authors:  J Hinman; J L Tullis; C A Saravis; R B Pennell
Journal:  Vox Sang       Date:  1967-07       Impact factor: 2.144

4.  Titered lots of immune globulin (Ig). Efficacy in the prevention of rubella.

Authors:  G M Schiff
Journal:  Am J Dis Child       Date:  1969-08

5.  [Elimination of complement fixation of gamma-globulin by chemical modification with beta-propiolactone].

Authors:  W Stephan
Journal:  Z Klin Chem Klin Biochem       Date:  1969-05

6.  Prevention of varicella by zoster immune globulin.

Authors:  P A Brunell; A Ross; L H Miller; B Kuo
Journal:  N Engl J Med       Date:  1969-05-29       Impact factor: 91.245

7.  Survival studies on a commercial preparation of intravenous human gammaglobulin labelled with 131-I.

Authors:  J V Wells; R Penny
Journal:  Australas Ann Med       Date:  1969-08

8.  Advisory committee on serum -globulins. Suitability for clinical use of immune serum globulin prepared from CPD plasma. A brief review.

Authors:  J T Sgouris
Journal:  Vox Sang       Date:  1971-05       Impact factor: 2.144

9.  [Longterm therapy with i.v.-gamma-globulin in children (author's transl)].

Authors:  B Kornhuber
Journal:  Monatsschr Kinderheilkd       Date:  1979-01

10.  [Prophylaxis and therapy with gamma globulin. General characterization and clinical use of gamma globulin preparations].

Authors:  S Barandun; F Skvaril; A Morell
Journal:  Schweiz Med Wochenschr       Date:  1976-04-17
View more
  1 in total

1.  [Immunoglobulins in the treatment of bacterial meningitis in childhood].

Authors:  R Noack; C Szugs; H Scholz
Journal:  Infection       Date:  1987 Jan-Feb       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.